N. White, Determinants of relapse periodicity in Plasmodium vivax malaria, Malaria Journal, vol.10, issue.1, p.297, 2011.
DOI : 10.1371/journal.pone.0009047

K. Battle, M. Karhunen, S. Bhatt, P. Gething, R. Howes et al., Geographical variation in Plasmodium vivax relapse, Malaria Journal, vol.13, issue.1, p.144, 2014.
DOI : 10.1097/QCO.0b013e32832f14c1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021508

R. Price, V. Seidlein, L. Valecha, N. Nosten, F. Baird et al., Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, The Lancet Infectious Diseases, vol.14, issue.10, pp.982-91, 2014.
DOI : 10.1016/S1473-3099(14)70855-2

A. Craig and K. Kain, Molecular Analysis of Strains of Plasmodium vivax from Paired Primary and Relapse Infections, Journal of Infectious Diseases, vol.174, issue.2, pp.373-382, 1996.
DOI : 10.1093/infdis/174.2.373

K. Kirchgatter, D. Portillo, and H. , Relapses Using the MSP1 Molecule as a Genetic Marker, The Journal of Infectious Diseases, vol.177, issue.2, pp.511-516, 1998.
DOI : 10.1086/517389

N. Chen, A. Auliff, K. Rieckmann, M. Gatton, and Q. Cheng, Infection Result from Clonal Hypnozoites Activated at Predetermined Intervals, The Journal of Infectious Diseases, vol.195, issue.7, pp.934-975, 2007.
DOI : 10.1086/512242

M. Imwong, G. Snounou, S. Pukrittayakamee, N. Tanomsing, J. Kim et al., Infection Usually Result from Activation of Heterologous Hypnozoites, The Journal of Infectious Diseases, vol.195, issue.7, pp.927-960, 2007.
DOI : 10.1086/512241

E. Restrepo, M. Imwong, W. Rojas, J. Carmona-fonseca, and A. Maestre, High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia, Acta Tropica, vol.119, issue.1, pp.23-32, 2011.
DOI : 10.1016/j.actatropica.2011.03.012
URL : http://doi.org/10.1016/j.actatropica.2011.03.012

F. Mckenzie, D. Smith, O. Meara, W. Riley, and E. , Strain theory of malaria: the first 50 years, Adv Parasitol, vol.66, pp.1-46, 2008.

W. Collins, G. Jeffery, and J. Roberts, A retrospective examination of reinfection of humans with Plasmodium vivax, Am J Trop Med Hyg, vol.70, pp.642-646, 2004.

G. Snounou and J. Pérignon, Malariotherapy ? Insanity at the Service of Malariology, Adv Parasitol, vol.81, pp.223-55, 2013.
DOI : 10.1016/B978-0-12-407826-0.00006-0

Y. Chaves, D. Costa, A. Pereira, M. , D. Lacerda et al., Immune response pattern in recurrent Plasmodium vivax malaria, Malaria Journal, vol.12, issue.Suppl 1, p.445, 2016.
DOI : 10.1016/S0167-5699(05)80015-5
URL : http://doi.org/10.1186/s12936-016-1501-5

R. Chuquiyauri, D. Molina, E. Moss, R. Wang, M. Gardner et al., Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection, The American Journal of Tropical Medicine and Hygiene, vol.93, issue.4, pp.801-810, 2015.
DOI : 10.4269/ajtmh.15-0232

W. Collins, M. Lunde, and J. Skinner, Development of Antibodies to Plasmodium Vivax as Measured by Two Different Serologic Techniques, The American Journal of Tropical Medicine and Hygiene, vol.24, issue.3, pp.412-418, 1975.
DOI : 10.4269/ajtmh.1975.24.412

S. Khusmith, S. Tharavanij, and D. Bunnag, Antigenic disparity of Plasmodium vivax causing initial symptoms and causing relapse, Southeast Asian J Trop Med Public Health, vol.29, pp.519-543, 1998.

J. Tobie, D. Abele, S. Wolff, P. Contacos, and C. Evans, Serum immunoglobulin levels in human malaria and their relationship to antibody production, J Immunol, vol.97, pp.498-505, 1966.

A. Llanos-cuentas, M. Lacerda, R. Rueangweerayut, S. Krudsood, S. Gupta et al., Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study, The Lancet, vol.383, issue.9922, pp.1049-58, 2014.
DOI : 10.1016/S0140-6736(13)62568-4

J. Baird, Chloroquine Resistance in Plasmodium vivax, Antimicrobial Agents and Chemotherapy, vol.48, issue.11, pp.4075-83, 2004.
DOI : 10.1128/AAC.48.11.4075-4083.2004
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC525399

E. Kamau, L. Tolbert, L. Kortepeter, M. Pratt, N. Nyakoe et al., Development of a Highly Sensitive Genus-Specific Quantitative Reverse Transcriptase Real-Time PCR Assay for Detection and Quantitation of Plasmodium by Amplifying RNA and DNA of the 18S rRNA Genes, Journal of Clinical Microbiology, vol.49, issue.8, pp.2946-53, 2011.
DOI : 10.1128/JCM.00276-11

S. Maneerattanasak, P. Gosi, S. Krudsood, J. Tongshoob, C. Lanteri et al., Genetic diversity among Plasmodium vivax isolates along the Thai?Myanmar border of Thailand, Malaria Journal, vol.20, issue.Suppl 1, p.75, 2016.
DOI : 10.1016/j.pt.2004.06.002
URL : https://hal.archives-ouvertes.fr/hal-01279472

M. Imwong, M. Boel, W. Pagornrat, M. Pimanpanarak, R. Mcgready et al., The First Plasmodium vivax Relapses of Life Are Usually Genetically Homologous, The Journal of Infectious Diseases, vol.205, issue.4, pp.680-683, 2012.
DOI : 10.1093/infdis/jir806

M. Imwong, S. Nair, S. Pukrittayakamee, D. Sudimack, J. Williams et al., Contrasting genetic structure in Plasmodium vivax populations from Asia and South America, International Journal for Parasitology, vol.37, issue.8-9, pp.1013-1035, 2007.
DOI : 10.1016/j.ijpara.2007.02.010

P. Tangteerawatana, H. Perlmann, M. Hayano, T. Kalambaheti, M. Troye-blomberg et al., IL4 gene polymorphism and previous malaria experiences manipulate anti-Plasmodium falciparum antibody isotype profiles in complicated and uncomplicated malaria, Malaria Journal, vol.8, issue.1, p.286, 2009.
DOI : 10.1186/1475-2875-8-286
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799430

N. Vanwong, N. Ngamsamut, Y. Hongkaew, N. Nuntamool, A. Puangpetch et al., Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels, Drug Metabolism and Pharmacokinetics, vol.31, issue.2, pp.156-62, 2016.
DOI : 10.1016/j.dmpk.2016.01.005

B. Pybus, S. Marcsisin, J. X. Deye, G. Sousa, J. Li et al., The metabolism of primaquine to its active metabolite is dependent on CYP 2D6, Malaria Journal, vol.12, issue.1, p.212, 2013.
DOI : 10.1007/s00210-003-0832-2

S. Zhou, J. Liu, and B. Chowbay, Polymorphism of human cytochrome P450 enzymes and its clinical impact, Drug Metabolism Reviews, vol.288, issue.1, pp.89-295, 2009.
DOI : 10.1124/mol.104.008086

J. Bennett, B. Pybus, A. Yadava, D. Tosh, J. Sousa et al., Malaria, New England Journal of Medicine, vol.369, issue.14, pp.1381-1383, 2013.
DOI : 10.1056/NEJMc1301936

R. Ingram, C. Crenna-darusallam, S. Soebianto, R. Noviyanti, and J. Baird, The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea, Malaria Journal, vol.13, issue.1, p.488, 2014.
DOI : 10.1128/AAC.01879-12

V. Kosaisavee, I. Hastings, A. Craig, and U. Lek-uthai, The genetic polymorphism of Plasmodium vivax genes in endemic regions of Thailand, Asian Pacific Journal of Tropical Medicine, vol.4, issue.12, pp.931-937, 2011.
DOI : 10.1016/S1995-7645(11)60221-6

J. Lin, J. Patel, O. Kharabora, J. Sattabongkot, S. Muth et al., Plasmodium vivax Isolates from Cambodia and Thailand Show High Genetic Complexity and Distinct Patterns of P. vivax Multidrug Resistance Gene 1 (pvmdr1) Polymorphisms, The American Journal of Tropical Medicine and Hygiene, vol.88, issue.6, pp.1116-1139, 2013.
DOI : 10.4269/ajtmh.12-0701

C. Luxemburger, K. Thwai, N. White, H. Webster, D. Kyle et al., The epidemiology of malaria in a Karen population on the western border of Thailand, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.90, issue.2, pp.105-116, 1996.
DOI : 10.1016/S0035-9203(96)90102-9

G. Coatney, W. Cooper, and M. Young, Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax, J Natl Malar Soc, vol.9, pp.381-96, 1950.

G. Jeffery, Relapses with Chesson Strain Plasmodium Vivax Following Treatment with Chloroquine, The American Journal of Tropical Medicine and Hygiene, vol.5, issue.1, pp.1-13, 1956.
DOI : 10.4269/ajtmh.1956.5.1

S. Jean, P. Xue, Z. Carter, N. Koh, G. Duparc et al., Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial, Malaria Journal, vol.17, issue.6 Suppl, p.97, 2016.
DOI : 10.1124/dmd.112.046425

M. Rijken, M. Boel, B. Russell, M. Imwong, M. Leimanis et al., Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand, Malaria Journal, vol.10, issue.1, p.113, 2011.
DOI : 10.1016/S0140-6736(98)09247-2
URL : https://hal.archives-ouvertes.fr/inserm-00654581

A. Bright, A. Thamer, S. Sandra, J. T. Giacomo, M. Nicholas et al., Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria, Emerging Infectious Diseases, vol.19, issue.5, p.802, 2013.
DOI : 10.3201/eid1905.121852

J. Park, S. Park, J. Yeom, A. Huh, Y. Cho et al., Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without thrombocytopenia

R. Rodrigues-da-silva, J. Lima-junior, P. Antas, A. Baldez, F. Storer et al., Alterations in cytokines and haematological parameters during the acute and convalescent phases of Plasmodium falciparum and Plasmodium vivax infections, Mem?rias do Instituto Oswaldo Cruz, vol.13, issue.2, pp.154-62, 2014.
DOI : 10.1155/2010/317430

J. Seoh, M. Khan, S. Park, H. Park, M. Shin et al., Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without hyperpyrexia, Am J Trop Med Hyg, vol.68, pp.102-108, 2003.

J. Yeom, S. Park, S. Ryu, H. Park, S. Woo et al., Serum cytokine profiles in patients with Plasmodium vivax malaria: A comparison between those who presented with and without hepatic dysfunction, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.97, issue.6, pp.687-91, 2003.
DOI : 10.1016/S0035-9203(03)80104-9

T. Liu, K. Lee, C. Chern, J. Cheng, A. Stern et al., Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB, Ann Clin Lab Sci, vol.31, pp.383-90, 2001.

A. Da-costa, L. Antonelli, P. Costa, J. Pimentel, N. Garcia et al., The robust and modulated biomarker network elicited by the Plasmodium vivax infection is mainly mediated by the IL-6/IL-10 axis and is associated with the parasite load, J Immunol Res, p.318250, 2014.

J. Wipasa, C. Suphavilai, L. Okell, J. Cook, P. Corran et al., Long-Lived Antibody and B Cell Memory Responses to the Human Malaria Parasites, Plasmodium falciparum and Plasmodium vivax, PLoS Pathogens, vol.137, issue.2, p.1000770, 2010.
DOI : 10.1371/journal.ppat.1000770.s001

C. Barnadas, A. Ratsimbasoa, M. Tichit, C. Bouchier, M. Jahevitra et al., Plasmodium vivax Resistance to Chloroquine in Madagascar: Clinical Efficacy and Polymorphisms in pvmdr1 and pvcrt-o Genes, Antimicrobial Agents and Chemotherapy, vol.52, issue.12, pp.4233-4273, 2008.
DOI : 10.1128/AAC.00578-08

Q. Wang, Z. Zhao, X. Zhang, X. Li, M. Zhu et al., Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia, PLOS ONE, vol.72, issue.3, p.151900, 2016.
DOI : 10.1371/journal.pone.0151900.s006